VenaSeal Enhancements

Simple innovations to the VenaSeal™ closure system plus new techniques mean greater* impact for you and your practice.
Play Video

Greater Efficencies

  • Streamlined inventory management and improved cash flow with new single-pack order option.
  • More efficient procedure.†1
  • Up to 1 minute less compression for every 9 cm of vein treated.†1

Hand compressing 9 cm segment of vein treated with improved VenaSeal closure system

Greater Control

New device removal technique to help contain adhesive to targeted vessel.1

Greater Ease of Use

Improved visibility of blue introducer markings for easier operation.1

VenaSeal closure system blue introducer with improved bolder, darker markings

New physician-preferred  straight floppy-tip guidewire.1

Great Outcomes

Same comfortable patient experience and great outcomes you’ve come to expect.2-5 Same safe and effective procedure, backed by long-term data.2-5

  • 94.6% Vein closure rate at 5 years2
  • 0 DVT (deep vein thrombosis)2
  • 0 PE (pulmonary embolism)2

Learn more about  VenaSeal closure system.

Discover Now
*

All statements of being “greater” are as compared to previous version and procedure technique.

With no change to safety and efficacy.

References

1

Medtronic data on file.

2

Morrison N, Gibson K, Vasquez M, et al. Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. November 2020;8(6):978-989.

3

Morrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. April 2015;61(4):985-994.

4

Proebstle T, Alm J, Dimitri S, et al. Three-year follow-up results of the prospective European Multicenter Cohort Study on Cyanoacrylate Embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. March 2021;9(2):329-334.

5

Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. September 2017;5(5):658-666.